Dongcheng Pharmaceutical: Announcement of Resolutions of the 16th Meeting of the 6th Board of Directors
Securities code: 002675 Securities abbreviation: Dongcheng Pharmaceutical Announcement number: 2025-073
Yantai Dongcheng Pharmaceutical Group Co., Ltd.
Announcement of Resolutions of the 16th Meeting of the 6th Board of Directors
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete.
False records, misleading statements or material omissions.
1. Convening of board of directors meetings
On December 15, 2025, Yantai Dongcheng Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company") held the 16th meeting of the sixth board of directors in the company conference room at No. 7 Changbaishan Road, Yantai Economic and Technological Development Zone, Shandong Province. The meeting notice will be delivered by communication on December 12, 2025. The meeting was held on-site and through communication. 9 directors were supposed to be present at the meeting, but 9 directors were actually present. All senior managers of the company attended the meeting. The meeting was chaired by Mr. Shou Yi, the chairman of the company, and the meeting was held in compliance with relevant regulations such as the Company Law of the People's Republic of China (hereinafter referred to as the "Company Law") and the Articles of Association of Yantai Dongcheng Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Articles of Association").
2. Review status of board of directors meeting
After deliberation, all directors reviewed and approved the following proposals on-site and through communication:
(1) Consideration and approval of the "Proposal on Subsidiaries' Application for Credit Lines from Banks"
For details, please refer to the company's "Announcement on Subsidiaries' Application for Credit Lines from Banks" published in "Securities Times", "Securities Daily", "China Securities News", "Shanghai Securities News" and cninfo.com (www.cninfo.com.cn).
Voting results: 9 votes in favor, 0 votes against, and 0 abstentions.
This proposal needs to be submitted to the company's shareholders' meeting for review.
(2) Consideration and approval of the “Proposal on the Purchase of Directors’ Liability Insurance”
For details, please refer to the company's "Announcement on the Purchase of Directors' Liability Insurance" published in "Securities Times", "Securities Daily", "China Securities Journal", "Shanghai Securities News" and Juchao Information Network (www.cninfo.com.cn).
In accordance with relevant regulations such as the Company Law and the Code of Governance for Listed Companies, the company plans to purchase directors' liability insurance, and the board of directors will request the company's shareholders' meeting to authorize the operating management to handle specific matters related to the purchase of directors' liability insurance. This proposal has been reviewed by the Company's Remuneration and Assessment Committee, and all members have abstained from voting and agreed to submit it to the Board of Directors for review.
In view that all directors are insurance targets and are interested parties, based on the principle of prudence, all directors of the board of directors abstained from voting and will directly submit it to the company's shareholders' meeting for review.
(3) Consideration and approval of the “Proposal on Convening the Third Extraordinary Shareholders’ Meeting in 2025”
The company's board of directors decided to convene the company's third extraordinary shareholders' meeting in 2025 on December 31, 2025. For details, please refer to the company's "Notice on Convening the Third Extraordinary Shareholders' Meeting in 2025" published in "China Securities Journal", "Shanghai Securities News", "Securities Times", "Securities Daily" and cninfo.com (www.cninfo.com.cn).
Voting results: 9 votes in favor, 0 votes against, and 0 abstentions.
3. Documents for reference
Board resolution signed by the directors present and stamped with the seal of the board of directors
Announcement hereby!
Board of Directors of Yantai Dongcheng Pharmaceutical Group Co., Ltd.
December 16, 2025